Member Info for Hurst10

What we need to remind ourselves of, is that the company is in close period, we have an ongoing AVA6000 phase one trial going on, with no negative feedback and we have imminent OTC approval,
With enormous overseas potential.
30 mill manufacturing capacity + another 30 mill
Update from the phase one trial at the day of the results, on any down day I am just buying more and so is key shareholders, we should keep an eye on RNS’

Stay calm, take advantage of nervous shareholders off loading.

New York Times this morning :
King County and Seattle announced that proof of vaccination or a negative COVID-19 test will be required to attend recreational activities indoor and outdoor, The New York Times reports.
Beginning Oct. 25, the health order extends to outdoor events with 500 or more people and indoor activities of any size, such as performances, movie theaters, conferences, gyms, restaurants and bars.
Customers who aren’t vaccinated or don’t have proof will instead need to show results of a negative coronavirus test taken within the past 72 hours.
Comment : this new development will spread to all over the States and off course could be the norm in the Europe.

All seen this ?

Transport secretary statement out shortly:
http://travelweekly.co.uk/news/air/move-to-two-tier-travel-system-with-lateral-flow-tests-predicted

The SPAC/ Prenetics story is hitting the US market, almost 07.00 AM and our buyer will continue.
When does LG step in ?

Delta variant expanding across Europe and further action is now expected from no10.
Meanwhile the news over night from Prenetics merging with a SPAC and the comment :
HONG KONG, Sept. 15, 2021 /PRNewswire/ -- Prenetics Group Limited ("Prenetics" or the "Company"), a global leader in genomic and diagnostic testing, and Artisan Acquisition Corp., a special purpose acquisition company privately founded by renowned cultural entrepreneur Adrian Cheng, announced today they have entered into a definitive merger agreement. Through combining with Artisan, Prenetics will draw upon Adrian's well-diversified business portfolio across retail, hospitality, healthcare, property and other strategic businesses, providing tremendous opportunities for closely aligned partnerships and allowing Prenetics to substantially expand its platform.
My comment:
This will only make LG Chem sit up and do this in South Korea with Avacta.
A unique JV with massive upside.
Comment have mentioned if needed, manufacturing output could be 30mill a month plus another substantial amount added,if needed.
Then Australia where Avacta have approval for professional use.

Only a question of time before this will happen to Avacta!
https://www.wsj.com/articles/prenetics-a-covid-testing-startup-to-go-public-in-spac-merger-11631745000

Tyra Biosciences stock opened at $29.90, or 86.9% above IPO price, before gaining gains.
A Precision oncology company developing purpose-built therapies to overcome tumour resistance.At pre clinical stage.
It shows how much Avacta?s precision oncology division is worth !!!

Absolutely, the report was ok, the valuation a bit too early.

However Stifel’s and others report have use the phrase, once full approval has been given for the LFT, considerable upside risk to earnings and target price

Read the broker report published some time ago, going through SOP based on various production levels for LFT’s and the price level of 365-760p was mentioned

Silence from the AVA6000 trials means nothing have gone wrong and one would assume at the numbers this will be confirm.
Will be an explosive market once ready, but even before phase 1 is completed, I would bet one a Major having signed and agreement with a hefty upfront payment and milestone payments going forward which will make headlines.
Meanwhile in the Covid OTC approval dept. , stand by!!

Pandemic Institute: Liverpool research base opens https://www.bbc.co.uk/news/uk-england-merseyside-58543721

https://www.escv2021.org/scientific-information/industry-symposia/

06.30 am NY time coming up !!
Watch best bid and worst offer price

Have a look at this one.
Will massively over subscribed !!!!

https://www.thearmchairtrader.com/storedot-ipo-could-this-be-the-hottest-listing-in-2021/

Another evidence of how much momentum Gene therapy is creating. AbbVie is expanding the ophthalmology segment of their pipeline today, bagging a gene therapy now in pivotal trials for wet age-related macular degeneration for a whopping $370 million in cash and adding $1.38 billion in milestone cash as a sweetener. And its new partners at Regenxbio also get support for future trial work.

Instant testing instead England vaccine passport plans ditched, Sajid Javid says https://www.bbc.co.uk/news/uk-58535258

Got this from the US another source, will find the official link. Do have it somewhere.

Huge coronavirus testing surge recorded among children

Sorry, did you mean the link to the US ETF’s buying ?

The opening link and will take you further.

https://www.gov.uk/government/news/cma-publishes-recommendations-to-improve-pcr-testing-market